Stock 688273 NANJING MEDLANDER MEDICAL TECHNOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Nanjing Medlander Medical Technology Co.,Ltd.

Equities

688273

CNE100005PV8

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 21/06/2024 am IST 		5-day change 1st Jan Change
20.35 CNY -2.02% Intraday chart for Nanjing Medlander Medical Technology Co.,Ltd. -1.36% -38.91%
31/05 Medlander Medical Technology Scraps 193 Million Yuan Maidou Health Deal MT
30/05 Nanjing Medlander Medical Technology Co.,Ltd. cancelled the acquisition of 55% stake in Nanjing Maidou Health Technology Co., Ltd. from Wu Henglong, Zheng Weifeng, Nanjing Xinlan Equity Investment Partnership (Limited Partnership) and Nanjing Maichuang Enterprise Management Partnership Enterprise (Limited Partnership) CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Medlander Medical Technology Scraps 193 Million Yuan Maidou Health Deal
MT
Nanjing Medlander Medical Technology Co.,Ltd. cancelled the acquisition of 55% stake in Nanjing Maidou Health Technology Co., Ltd. from Wu Henglong, Zheng Weifeng, Nanjing Xinlan Equity Investment Partnership (Limited Partnership) and Nanjing Maichuang Enterprise Management Partnership Enterprise (Limited Partnership)
CI
Nanjing Medlander Medical Technology Acquiring 55% Stake in Nanjing Maidou Health Technology
MT
Nanjing Medlander Medical Technology Co.,Ltd. agreed to acquire 55% stake in Nanjing Maidou Health Technology Co., Ltd. from Wu Henglong, Zheng Weifeng, Nanjing Xinlan Equity Investment Partnership (Limited Partnership) and Nanjing Maichuang Enterprise Management Partnership Enterprise (Limited Partnership) for CNY 190 million.
CI
Nanjing Medlander Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Medlander Medical Technology Buys Back Shares for 31 Million Yuan
MT
Tranche Update on Nanjing Medlander Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on August 23, 2023.
CI
Nanjing Medlander Medical Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tranche Update on Nanjing Medlander Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on August 23, 2023.
CI
Nanjing Medlander Medical Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tranche Update on Nanjing Medlander Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on August 23, 2023.
CI
Nanjing Medlander Medical Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Nanjing Medlander Medical Technology Co.,Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.
CI
Nanjing Medlander Medical Technology Co.,Ltd. authorizes a Buyback Plan.
CI
Medlander Medical’s Chairman Proposes Up to 40 Million Yuan Share Buyback
MT
Certain A Shares of Nanjing Medlander Medical Technology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 11-AUG-2023.
CI
Nanjing Medlander Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Nanjing Medlander Medical Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Zhu Bisheng agreed to acquire 10% stake in Nanjing Reseader Medical Technology Co., Ltd. from Nanjing Medlander Medical Technology Co.,Ltd. for CNY 0.332 million.
CI
Nanjing Medlander Medical Technology Co.,Ltd. has completed an IPO in the amount of CNY 1.00725 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688273 Stock
  4. News Nanjing Medlander Medical Technology Co.,Ltd.
  5. Highlights